Pfizer pays $7.5m regulatory milestone to Auxilium
Pfizer has paid $7.5m as regulatory milestone to Auxilium Pharmaceuticals related to the first sale of Xiapex in Germany as a treatment for Dupuytren's contracture.
Pfizer Inc. said yesterday it paid US$35-million to about 4,500 doctors and researchers from July through December 2009 for a variety of services, including speaking fees, expert advice and work on clinical trials of its medicines.